Also trades as: OTC.V (TSXV) · $vol 0M
OTCFF OTC
Ocumetics Technology Corp.
1W: -22.1%
1M: +11.2%
3M: -27.6%
YTD: -31.2%
1Y: -67.5%
3Y: +3.8%
$0.31
-0.01 (-2.69%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$18.3M
52W Range0.26-0.96
Volume8,000
Avg Volume8,371
Beta0.34
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODean E. Burns
Employees3
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2021-11-01
Websiteocumetics.com
639-5th Avenue SW
Calgary, AB T2P 0M9
CA
Calgary, AB T2P 0M9
CA
+1 604 283 5517
About Ocumetics Technology Corp.
Specializing in research and product development, Ocumetics Technology Corp. engineers and manufactures a range of optical lenses. A flagship offering is the Bionic Lens, an innovative, expandable intraocular lens designed to be precisely placed within the eye's natural lens capsule, thereby removing the necessity for traditional corrective eyewear. The company's operations are headquartered in Calgary, Canada.
Latest News
Ocumetics Reports Positive Three Month First-in-Human Results, Significantly De-Risking Its Accommodating Intraocular Lens Technology
Ocumetics Announces Proposed Forbearance Agreement for $4 million Secured Convertible Debentures
Ocumetics Announces Transition of Chief Medical Officer Consulting Role
Ocumetics Technology Announces Closing of First Tranche of Brokered LIFE Offering Led by Centurion One Capital
Ocumetics Technology Announces Amendment to Brokered LIFE Offering Led by Centurion One Capital
Recent Insider Trades
No insider trades found